J0752
HCPCSHiv prep, oral lenacapavir
Official HCPCS Level II long descriptor
Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
HCPCS Level II code J0752 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Hiv prep, oral lenacapavir
Added to HCPCS: 2025-10-01
Nearby codes in J0
- J0740Cidofovir injection
- J0741Inj, cabote rilpivir 2mg 3mg
- J0742Inj imip 4 cilas 4 releb 2mg
- J0743Cilastatin sodium injection
- J0744Ciprofloxacin iv
- J0745Inj codeine phosphate /30 mg
- J0750Hiv prep, ftc/tdf 200/300mg
- J0751Hiv prep, ftc/taf 200/25mg
- J0759Inj, clevidipine, 1 mg
- J0770Colistimethate sodium inj
- J0775Collagenase, clost hist inj
- J0780Prochlorperazine injection
- J0791Inj crizanlizumab-tmca 5mg
- J0799Hiv prep, fda approved, noc
- J0801Inj. acthar gel to 40 units
- J0802Inj. (ani), up to 40 units
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.